During the past decade, Diabetespraxis Mergentheim conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Diabetespraxis Mergentheim" are "Type 2 Diabetes" (2 trials) and "Type 2 Diabetes Treated With Insulin" (1 trials). Many other conditions were trialed in "Diabetespraxis Mergentheim" in a lesser frequency.

Most popular intervention types in "Diabetespraxis Mergentheim" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Antihyperglycemic medication" (1 trials), "Insulin Efsitora Alfa" (1 trials), "Insulin Glargine (U100)" (1 trials), "Insulin Lispro (U100)" (1 trials) and "Tirzepatide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Diabetespraxis Mergentheim" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Diabetespraxis Mergentheim". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Diabetespraxis Mergentheim, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Diabetespraxis Mergentheim, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".